Eltrombopag

BNF:
9.1
Status:
Do Not Prescribe (DNP), Red
Decision Date:
August 2013
 

Comments

RED:1,2,3 NICE TA293: for treating chronic immune (idiopathic) thrombocytopenic purpura

DO NOT PRESCRIBE (DNP)6: NICE TA382 for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) (Decision date - February 2016)

Black Drug Classifications

  • 6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again